Literature DB >> 117509

First principles of cost-effectiveness analysis in health.

D S Shepard, M S Thompson.   

Abstract

Mesh：

Year:  1979        PMID： 117509      PMCID： PMC1431742     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN： 0033-3549            Impact factor:   2.792


× No keyword cloud information.
  7 in total

1.  Health status: types of validity and the index of well-being.

Authors:  R M Kaplan; J W Bush; C C Berry
Journal:  Health Serv Res       Date:  1976       Impact factor: 3.402

2.  Benefit-cost analysis: a review of its applicability in policy analysis for delivering health services.

Authors:  D W Dunlop
Journal:  Soc Sci Med       Date:  1975-03       Impact factor: 4.634

3.  National health insurance and the sixth stool guaiac.

Authors:  D Neuhauser; A M Lewicki
Journal:  Policy Anal       Date:  1976

4.  Public-health rounds at the Harvard School of Public Health. Allocation of resources to manage hypertension.

Authors:  W B Stason; M C Weinstein
Journal:  N Engl J Med       Date:  1977-03-31       Impact factor: 91.245

5.  Foundations of cost-effectiveness analysis for health and medical practices.

Authors:  M C Weinstein; W B Stason
Journal:  N Engl J Med       Date:  1977-03-31       Impact factor: 91.245

6.  The utility of different health states as perceived by the general public.

Authors:  D L Sackett; G W Torrance
Journal:  J Chronic Dis       Date:  1978

7.  Fallacy of the five-year survival in lung cancer.

Authors:  B J McNeil; R Weichselbaum; S G Pauker
Journal:  N Engl J Med       Date:  1978-12-21       Impact factor: 91.245
  7 in total
  19 in total

1.  Principles of pharmacoeconomic analysis of drug therapy.

Authors:  D A Freund; R S Dittus
Journal:  Pharmacoeconomics       Date:  1992-01       Impact factor: 4.981

2.  Preference based outcome measures for economic evaluation of drug interventions: quality adjusted life years (QALYs) versus healthy years equivalents (HYEs).

Authors:  A Mehrez; A Gafni
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

3.  Discounting of health benefits in the pharmacoeconomic analysis of drug therapies: an issue for debate?

Authors:  D Coyle; K Tolley
Journal:  Pharmacoeconomics       Date:  1992-08       Impact factor: 4.981

4.  Economic decision making in healthcare. A standard approach to discounting health outcomes.

Authors:  A L Hillman; M S Kim
Journal:  Pharmacoeconomics       Date:  1995-03       Impact factor: 4.981

5.  A method to measure the costs of counseling for HIV prevention.

Authors:  R D Gorsky
Journal:  Public Health Rep       Date:  1996       Impact factor: 2.792

6.  Clinical and economic evaluation of benzodiazepines: a value analysis.

Authors:  J S Lyons; D B Larson; J Hromco
Journal:  Pharmacoeconomics       Date:  1992-11       Impact factor: 4.981

7.  Economic comparison of enzyme immunoassay and virus isolation procedures for surveillance of arboviruses in mosquito populations.

Authors:  S W Hildreth; B J Beaty
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

8.  The standard gamble method: what is being measured and how it is interpreted.

Authors:  A Gafni
Journal:  Health Serv Res       Date:  1994-06       Impact factor: 3.402

9.  Newborn circumcision: an economic perspective.

Authors:  D Cadman; A Gafni; J McNamee
Journal:  Can Med Assoc J       Date:  1984-12-01       Impact factor: 8.262

10.  Weight loss competitions at the work site: impact on weight, morale and cost-effectiveness.

Authors:  K D Brownell; R Y Cohen; A J Stunkard; M R Felix; N B Cooley
Journal:  Am J Public Health       Date:  1984-11       Impact factor: 9.308
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.